DR. MARTIN ROSE, M.D.
Osteopathic Medicine at Kenhill Rd, Bethesda, MD
License number
Maryland G23558
Category
Osteopathic Medicine
Type
Endocrinology, Diabetes & Metabolism
Address
Address
6709 Kenhill Rd, Bethesda, MD 20817
Phone
(301) 229-8673
(301) 229-8674 (Fax)
(301) 229-8674 (Fax)
Organization information
See more information about MARTIN ROSE at bizstanding.comMartin Rose MD
6709 Kenhill Rd, Bethesda, MD 20817
Industry:
Internist
Phone:
(301) 229-8673 (Phone)
Martin Christopher Rose
Professional information
Colonic Purgative Composition With Soluble Binding Agent
US Patent:
7687075, Mar 30, 2010
Filed:
Nov 16, 2004
Appl. No.:
10/988693
Inventors:
Stephen Skiendzielewski - Norristown PA, US
Martin Rose - Bethesda MD, US
Ngoc Do - Bel Air MD, US
Martin Rose - Bethesda MD, US
Ngoc Do - Bel Air MD, US
Assignee:
Salix Pharmaceuticals, Ltd. - Morrisville NC
International Classification:
A61K 33/42, A61K 9/20, A61K 31/66
US Classification:
424606, 424464, 514 75
Abstract:
This invention relates to novel colonic purgative compositions in a solid dosage form, comprising at least one purgative and at least one soluble, or soluble, nonfermentable binder, such as polyethylene glycol. Further, this invention relates to methods of using the colonic purgative compositions. The present compositions and methods are designed to improve patient tolerance and compliance, while at the same time improving the quality of bowel cleansing. The formulations and methods of this invention are particularly useful to cleanse the bowel prior to diagnostic and surgical procedures and can also be employed in lower dosages as a laxative to promote elimination and/or to relieve constipation.
Colonic Purgative Composition With Soluble Binding Agent
US Patent:
7718197, May 18, 2010
Filed:
Mar 13, 2008
Appl. No.:
12/075772
Inventors:
Stephen Skiendzielewski - Norristown PA, US
Martin Rose - Bethesda MD, US
Ngoc Do - Bel Air MD, US
Martin Rose - Bethesda MD, US
Ngoc Do - Bel Air MD, US
Assignee:
Salix Pharmaceuticals, Ltd. - Morrisville NC
International Classification:
A61K 33/42, A61K 9/20, A61K 31/66
US Classification:
424606, 424464, 514 75
Abstract:
This invention relates to novel colonic purgative compositions in a solid dosage form, comprising at least one purgative and at least one soluble, or soluble, nonfermentable binder, such as polyethylene glycol. Further, this invention relates to methods of using the colonic purgative compositions. The present compositions and methods are designed to improve patient tolerance and compliance, while at the same time improving the quality of bowel cleansing. The formulations and methods of this invention are particularly useful to cleanse the bowel prior to diagnostic and surgical procedures and can also be employed in lower dosages as a laxative to promote elimination and/or to relieve constipation.
Colonic Purgative Composition With Soluble Binding Agent
US Patent:
8507009, Aug 13, 2013
Filed:
Jan 20, 2010
Appl. No.:
12/690384
Inventors:
Stephen Skiendzielewski - Norristown PA, US
Martin Rose - Bethesda MD, US
Ngoc Do - Bel Air MD, US
Martin Rose - Bethesda MD, US
Ngoc Do - Bel Air MD, US
Assignee:
Salix Pharmaceuticals, Inc. - Raleigh NC
International Classification:
A61K 33/42, A61K 9/46, A61K 31/66
US Classification:
424606, 424466, 514 75
Abstract:
This invention relates to novel colonic purgative compositions in a solid dosage form, comprising at least one purgative and at least one soluble, or soluble, nonfermentable binder, such as polyethylene glycol. Further, this invention relates to methods of using the colonic purgative compositions. The present compositions and methods are designed to improve patient tolerance and compliance, while at the same time improving the quality of bowel cleansing. The formulations and methods of this invention are particularly useful to cleanse the bowel prior to diagnostic and surgical procedures and can also be employed in lower dosages as a laxative to promote elimination and/or to relieve constipation.
Dr. Martin Rose, Bethesda MD - MD (Doctor of Medicine)
Specialties:
Internal Medicine
Address:
6709 Kenhill Rd, Bethesda 20817
(301) 229-8673 (Phone), (301) 229-8674 (Fax)
(301) 229-8673 (Phone), (301) 229-8674 (Fax)
Certifications:
Internal Medicine, 1975
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
University of California At San Francisco
St Marys Medical Center
San Francisco Va Hosp
University of California At San Francisco
St Marys Medical Center
San Francisco Va Hosp
Polyethylene Glycol Colonic Purgative Composition
US Patent:
2008026, Oct 23, 2008
Filed:
Nov 2, 2007
Appl. No.:
11/982603
Inventors:
Martin Rose - Bethesda MD, US
Robert Apple - Newtown PA, US
Stephen Skiendzielewski - Cary NC, US
Robert Apple - Newtown PA, US
Stephen Skiendzielewski - Cary NC, US
Assignee:
Salix Pharmaceuticals, Inc. - Morrisville NC
International Classification:
A61K 31/765, A61P 1/10
US Classification:
424 7838
Abstract:
This invention relates to novel colonic purgative compositions of polyethylene glycol having an average molecular weight of at least 1,000 or at least 4,000. Further, this invention relates to methods of using the colonic purgative compositions. The formulations and methods of this invention are particularly useful to cleanse the bowel prior to diagnostic and surgical procedures and can also be employed in lower dosages as a laxative to promote elimination and/or to relieve constipation.
Purgative Composition And Uses Thereof
US Patent:
2006024, Nov 2, 2006
Filed:
Apr 29, 2005
Appl. No.:
11/117436
Inventors:
James Bergey - Chester Springs PA, US
Martin Rose - Bethesda MD, US
Martin Rose - Bethesda MD, US
International Classification:
A61K 31/7012, A61K 31/70, A61K 31/715
US Classification:
514023000, 514053000, 514061000
Abstract:
A purgative composition containing a purgative effective amount of a halogenated carbohydrate is disclosed.
Martin Rose, Bethesda MD - Lawyer
Address:
6709 Kenhill Rd, Bethesda 20817
(301) 229-8673
(301) 229-8673
Licenses:
Dist. of Columbia - Active 1981